VXTRQ yields 6666666.67% · PFE yields 6.13%● Live data
📍 VXTRQ pulled ahead of the other in Year 1
Combined, VXTRQ + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VXTRQ + PFE for your $10,000?
Voxtur Analytics Corp. operates as a real estate technology company in the United States and Canada. The company offers ReboGateWay Pro, a live format for automatic property updates and alerts on changes within farms/lists; Title Toolbox, a tool that provides property data in a live format for automatic property updates and alerts; Investor Toolbox, an access to all property and farming tools; Lender Toolbox provides targeted data to pinpoint homeowners to exact lending program criteria for various lending options; Premier Lists, a custom data list service designed to create prospect list for a specific area; TaxExpress, a tax certificate solution; and O and E QuickCheck, a data intelligence report for real estate that evaluate loans or portfolios and close, Voxtur Verify and Data Connect. It also provides Anow SaaS Appraiser product, tool for appraisers and analysts to manage valuation orders, employees, scheduling, accounting, client communication, and reporting; Voxtur Direct, an appraisal management solution; and Reports Now, an automated report builder. In addition, the company offers AOL, a full-coverage title alternative; residential and commercial services; default to manage loan portfolio; insured title products that protect purchasers and lenders against defects in title; and uninsured title products. Further, it provides Real Property Tax Analytics for transparency and insight; ApexSketch, a line of software applications designed to build floorplan sketches; ApexSketch Portal which allow users to save Property Sketch Data; GeoViewport to aggregate visual property data into one location; StreetScape, a visual and data intelligence product; Apex Professional Services; consulting practice focused on property assessment; and technology-enabled solutions related to property tax. The company is based in London, Canada.
Full VXTRQ Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.